Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Cited In for PubMed (Select 17118626)

1.

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder.

Levitan MN, Papelbaum M, Nardi AE.

Neuropsychiatr Dis Treat. 2015 May 5;11:1149-55. doi: 10.2147/NDT.S67470. eCollection 2015. Review.

2.

Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches.

Snyder HR, Miyake A, Hankin BL.

Front Psychol. 2015 Mar 26;6:328. doi: 10.3389/fpsyg.2015.00328. eCollection 2015. Review.

3.

The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review.

Haller H, Cramer H, Lauche R, Gass F, Dobos GJ.

BMC Psychiatry. 2014 May 1;14:128. doi: 10.1186/1471-244X-14-128.

4.

Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristics.

Burstein M, Beesdo-Baum K, He JP, Merikangas KR.

Psychol Med. 2014 Aug;44(11):2351-62. doi: 10.1017/S0033291713002997. Epub 2014 Jan 2.

5.

Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample.

Zbozinek TD, Rose RD, Wolitzky-Taylor KB, Sherbourne C, Sullivan G, Stein MB, Roy-Byrne PP, Craske MG.

Depress Anxiety. 2012 Dec;29(12):1065-71. doi: 10.1002/da.22026. Epub 2012 Nov 26.

6.

Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN Study.

Alvarez E, Carrasco JL, Olivares JM, López-Gómez V, Vilardaga I, Perez M.

Clin Pract Epidemiol Ment Health. 2012;8:158-68. doi: 10.2174/1745017901208010158. Epub 2012 Nov 16.

7.

Generalized anxiety disorder and the proposed associated symptoms criterion change for DSM-5 in a treatment-seeking sample of anxious youth.

Comer JS, Pincus DB, Hofmann SG.

Depress Anxiety. 2012 Dec;29(12):994-1003. doi: 10.1002/da.21999. Epub 2012 Sep 5.

9.
10.

The WHO World Mental Health (WMH) Surveys.

Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ustün TB.

Psychiatrie (Stuttg). 2009 Jan 1;6(1):5-9.

11.

Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

Davidson JR, Feltner DE, Dugar A.

Prim Care Companion J Clin Psychiatry. 2010;12(2). pii: PCC.09r00772. doi: 10.4088/PCC.09r00772blu.

12.

Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V.

Beesdo K, Knappe S, Pine DS.

Psychiatr Clin North Am. 2009 Sep;32(3):483-524. doi: 10.1016/j.psc.2009.06.002. Review.

13.

Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

Gao K, Sheehan DV, Calabrese JR.

Expert Rev Neurother. 2009 Aug;9(8):1147-58. doi: 10.1586/ern.09.37. Review.

14.

The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys.

Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, Ustün TB, Wang PS.

Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33.

15.

Assessment of anxiety in older home care recipients.

Diefenbach GJ, Tolin DF, Meunier SA, Gilliam CM.

Gerontologist. 2009 Apr;49(2):141-53. doi: 10.1093/geront/gnp019. Epub 2009 Mar 27.

16.

Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.

Lee S, Tsang A, Ruscio AM, Haro JM, Stein DJ, Alonso J, Angermeyer MC, Bromet EJ, Demyttenaere K, de Girolamo G, de Graaf R, Gureje O, Iwata N, Karam EG, Lepine JP, Levinson D, Medina-Mora ME, Oakley Browne MA, Posada-Villa J, Kessler RC.

Psychol Med. 2009 Jul;39(7):1163-76. doi: 10.1017/S0033291708004807. Epub 2008 Dec 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk